Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

COVID-19 Vaccine Corporation Partners With The University Of Queensland

AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined forces with the University of Queensland in its vaccine production efforts.

After halting development of its spike protein based candidate in December, CVC continues to progress development of its proprietary T-cell vaccine.

Its T-cell vaccine is designed to work with other existing vaccines in order to improve efficacy, lengthen immunity time and to protect against all new variants for the SARS-Cov-2 virus, including those from Britain and South Africa.

CVC’s efforts and new partnership are particularly timely in the wake of South African government’s attempt to recall a million doses of the Astra-Zeneca-Oxford vaccine candidate due to concerns of its limited efficacy against the country’s local variant of the virus.

CVC is collaborating with the Protein Expression Facility (PEF) at The University of Queensland, who offer exceptional experience and expertise in making peptides and proteins in bacteria. PEF are now working on making two versions of CVC’s T-cell vaccine.

“It is exciting to be working with PEF who are an excellent group with a huge knowledge of microbial expression and fermentation. Their expertise is just what we need at this stage of our development and I look forward to a successful outcome of the collaboration,” says CVC Chief Executive Dr Robert Feldman.

PEF are helping CVC produce a soluble T-cell vaccine antigen as CVC simultaneously progresses its biobead version of the T-cell vaccine, using technology licensed from PolyBatics Ltd.

PEF Strategy and Operations Manager Dr Balaji Somasundaram says producing high-quality proteins is a critical first step for vaccine development. “A suite of protein analytics will verify the quality of the T-cell vaccine antigens,” Dr Somasundaram said.

PEF was founded by Professor Linda Lua to enable researchers and biotechnology companies with innovative solutions for protein production. “We are pleased to support CVC to accelerate the development of its proprietary T-cell vaccine,” says Professor Lua.

CVC intends to test both soluble and biobead versions of its T-cell vaccines head-to-head later this year and progress with the most promising version.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Paymark: Lockdown Equals Slowdown For Some

The three days of lockdown for Auckland earlier this month made a clear impression on our retail spending figures. While only Auckland moved into Level 3 lockdown, the impact was felt across the country, albeit at different levels. Looking at the ... More>>

Infrastructure Commission: Te Waihanga Releases Report On Water Infrastructure

The New Zealand Infrastructure Commission, Te Waihanga’s latest discussion document highlights the importance of current reforms in the water sector. Its State of Play discussion document about water infrastructure is one of a series looking at the ... More>>

Sci-Tech: Perseverance Rover Lands On Mars – Expert Reaction

NASA has landed a car-sized rover on the red planet to search for signs of past life. The vehicle has more instruments than the four rovers preceding it, and it’s also carrying gear that could help pave the way for human exploration of Mars. The ... More>>

ALSO:


ASB: Quarterly Economic Forecast Predicts OCR Hike As Early As August 2022

Predictions of interest rate rises have been brought forward 12 months in ASB’s latest Quarterly Economic Forecast. Chief Economist Nick Tuffley now expects the RBNZ to begin raising the OCR from its current level of 0.25% as early as August ... More>>

ACT: Matariki Almost A Half Billion Dollar Tax On Business

“Official advice to the Government says an extra public holiday at Matariki could cost almost $450 million,” ACT Leader David Seymour can reveal. “This is a perfect example of the Prime Minister doing what’s popular versus what’s responsible. ... More>>

Genesis: Assessing 6,000 GWh Of Renewable Generation Options For Development By 2025

Genesis is assessing 6,000 GWh of renewable generation options for development after starting a closed RFP process with 11 partners. Those invited to participate offer a range of technologies as Genesis continues to execute its Future-gen strategy to ... More>>

OECD: Unemployment Rate Stable At 6.9% In December 2020, 1.7 Percentage Points Higher Than In February 2020

The OECD area unemployment rate was stable at 6.9% in December 2020, remaining 1.7 percentage points above the level observed in February 2020, before the COVID-19 pandemic hit the labour market. [1] In December, the unemployment rate was also stable ... More>>

Stats NZ: Unemployment Drops To 4.9 Percent As Employment Picks Up

The seasonally adjusted unemployment rate dropped to 4.9 percent in the December 2020 quarter, from 5.3 percent in the September 2020 quarter, Stats NZ said today. Last quarter’s unemployment rate of 5.3 percent followed the largest increase observed ... More>>